Skip to main content
. 2000 May;182(10):2937–2944. doi: 10.1128/jb.182.10.2937-2944.2000

TABLE 1.

Bacterial strains and plasmids

Strain or plasmid Relevant characteristicsa Source or reference
Strains
V. cholerae
  N18 Wild-type O1: Peru 1991 J. M. Fournier (Institut Pasteur)
  SV1 N18 nhaA mutant This work
  SV2 N18 nhaA′-lacZ nhaA mutant This work
  SV3 N18 PnhaA′-lacZ This work
E. coli
  TG1 F′ traD36 lacIq Δ(lacZ)M15 proA+B+/supE Δ(hsdM-mcrB)5 (rK mK McrB) thi Δ(lac-proAB) Biolabs
  DH5α λpir recA1 gyrA (Nal) Δ(lacIZYA-argF) (φ80dlacΔ [lacZ]M15) pirRK6 27
  β2155 F′ traD36 lacIq Δ(lacZ)M15 proA+B+/thr-1004 pro thi strA hsdS Δ(lacZ)M15 ΔdapA::erm pir::RP4(::Kan from SM10) D. Mazel (Institut Pasteur) and unpublished data
  TA15 melBLid nhaA+ ΔlacZY 17
  NM81 TA15 ΔnhaA1::kan+ thr-1 32
  HITΔAB− HIT-1(nhaB mutant) ΔnhaA::Kanr 51
Plasmids
 pBR322 Ap Tc 53
 pHG329 Ap 47
 pUC1318ΩKm1 Ap Km; a pUC1318 derivative with a 1.5-kb ClaI fragment containing aphA-3 inserted at the SmaI site P. Trieu-Cuot, unpublished data
 pAT113/Sp Sp Mob+ (IncP), oriR pACYC184, att Tn1545, lacZα+, MCS pUC19 8
 plac-1 A pGP704 derivative with lacZ 1
a

Ap, Tc, Nal, Km or Kan, and Sp, resistance to ampicillin, tetracycline, nalidixic acid, kanamycin and streptomycin, respectively.